PROCESS FOR CONVERSION OF CERTAIN TRANS 3,4-METHANO-PYRROLIDINE DERIVATIVES INTO THEIR CORRESPONDING CIS ISOMERS, A NOVEL UNSATURATED INTERMEDIATE IN THE PROCESS AND DERIVATIVES THEREOF, A PROCESS FOR PREPARING THE NOVEL INTERMEDIATE AND DERIVATIVES THEREOF, POLLEN-SUPPRESSING COMPOSITIONS AND A METHOD OF PRODUCING F1HYBRID SEED

Abstract: A process for the conversion of the trans isomer of an acid whose carbon skeleton includes the unit or a salt, ester, or salt of an ester thereof, into the cis isomer of such a compound which comprises converting the trans isomer into an acid whose carbon skeleton includes the unit or a salt thereof, and subsequently hydrogenating said com­ pound and, in the event of an ester or salt thereof being required converting the resulting free acid or salt thereof into the required ester or salt thereof. The compound 2-­ carboxy-3-aza-bicyclo 3.1.0 hex-2-ene or a salt and/or amide, alkylamide, hydrazide or alkylhydrazide thereof may be used as a pollen suppressant.

Description: Process for conversion of certain trans 3,4-methano-pyrrolidine derivatives into their corresponding cis isomers, a novel unsaturated intermediate in the process and derivatives thereof, a process for preparing the novel intermediate and derivatives thereof, pollen-suppressing compositions and a method of producing F1 hybrid seed This invention relates to a process for the isomerisation of derivatives of 3-azabicycloC3.1.03 hexane, and to novel compositions useful as pollen suppressants. 2-Carboxy-3-azabicyclo [3.1. o3 hexane and certain derivatives thereof have exhibited extremely useful plant growth regulating and pollen suppressing properties. The single isomer cis (L) 2-carboxy-3-azabicyclo 03.1.0]hexane is found in the seeds of the American horse chestnut in small amounts, and much research has been directed to developing a synthetic method of producing this and the other isomers in larger amounts. A method has now been found by which trans 2-carboxy-3 azabicyclot3.1.0qhexane and derivatives thereof can be converted into the corresponding cis isomer. The invention provides a process for the conversion of the trans isomer of an acid whose carbon skeleton includes the unit EMI1.1 or a salt, ester, or salt of an ester thereof, into the cis isomer of such a compound, which comprises converting the trans isomer into an acid whose carbon skeleton includes the unit EMI2.1 or a salt thereof, and subsequently hydrogenating said compound; and, in the event of an ester or salt thereof being required, converting the resulting free acid or salt thereof into the desired ester or salt thereof. Various possibilities for isomerism exist, of course, depending upon the nature of substituents on the bicyclic nucleus. However, throughout this specification, a trans isomer should be understood to be a geometric isomer in which the -CO2- group in the 2-position of the 3-azabicyclohexane ring is trans to the bridging group in the 6-position, and a cis isomer is a geometric isomer in which the :CO,- group is cis to the bridging group. It should be noted that for each such geometric isomer, a pair of optical isomers exists, due to the asymmetry of the 2carbon atom. The starting trans compound may be either pure trans isomer or it may be present in a mixture of cis and trans isomers. Thus any mixture of cis and trans isomers may be converted into cis compounds, or into a mixture of trans and cis compounds containing an enhanced proportion of cis isomer, by the process of the invention. If desired, the product obtained directly from the hydrogenation process, which is an acid or a salt thereof, may be converted into an ester or a salt thereof. This may be performed by any suitable method known for the preparation of esters and salts thereof. Preferably the carbon skeletons I and II are substituted only by hydrogen atoms. The starting material may be a free acid I or a salt thereof, for example an alkali metal salt or a hydrohalide salt. Preferably, however, an ester is used as starting material. The ester may for example be an alkyl, alkenyl, alkynyl, aryl or aralkyl ester in which the ester moiety may be unsubstituted or substituted by one or more of the same or different substituents selected from halogen atoms, alkyl groups and alkoxy groups. Preferably the ester is an alkyl, alkenyl or aralkyl ester in which the ester moiety is unsubstituted. More preferably the ester is an alkyl ester having from 1 to 10, especially 1 to 4 carbon atoms in the alkyl group. For example, the ester may be a methyl, ethyl or isopropyl ester. If an ester or salt thereof, for example a hydrohalide salt thereof, is used as starting material, it is suitably converted to the acid II or salt thereof in two stages. Firstly, it is converted into an ester of the acid II, and secondly, the ester is hydrolysed. The conversion of the starting ester to an ester of the acid II may for example be carried out directly using an oxidising agent. Manganese dioxide is a suitable reagent, and the oxidation can be performed simply by stirring the ester of the compound of formula II with manganese dioxide in the presence of a suitable solvent, for example a hydrocarbon such as benzene or light petroleum. The reaction is conveniently performed at room temperature. Alternatively, the conversion may be carried out indirectly for example by chlorinating or brominating the ester of an acid whose carbon skeleton includes the unit I to give an ester of an acid whose carbon skeleton includes the unit EMI3.1 in which Hal is a chlorine or bromine atom, and subsequently dehydrohalogenating the N-halo compound. The halogenation may be carried out using any suitable halogenating agent, for example Nbromo- or, especially, N-chlorosuccinimide, or an organic or inorganic hypohalite, for example t-butyl hypochlorite or sodium hypochlorite. Sodium hypochlorite may conveniently be used in the form of sodium hydroxide plus chlorine. The halogenation is suitably carried out by admixing the halogenating agent with the starting ester. Any suitable solvent, for example an ether, may be used. Water is a suitable solvent when using an inorganic halogenating agent. The reaction may for example be carried out at a temperature in the range of from -lO0C to +300C, the optimum temperature depending on the halogenating agent used. For example, if a hypohalite is used as halogenating agent, the reaction is preferably carried out at a temperature in the range of from -10 C to +5 C, whereas if N-chlorosuccinimide is used as halogenating agent, the reaction is most conveniently carried out at room temperature. Suitable dehydrohalogenating agents for the dehydrohalogenation step include organic bases and inorganic bases, for example an alkali metal hydroxide or alkoxide, or a tertiary amine, for example triethylamine. If it is desired to isolate the ester of the acid whose carbon skeleton includes the unit II, care should be taken to ensure that the reaction conditions are such that the ester group is not attacked. For this reason, the base used should be relatively non-nucleophilic; for example, sodium ethoxide is generallv preferred to sodium hydroxide. The reaction may be carried out in any suitable polar solvent, for example an ether or an alcohol, and is preferably carried out at a temperature of up to 150 C, preferably at a temperature in the range 0 to 80 C. The resulting azabicyclohexene ester may be isolated by any suitable method, or at least part of the reaction mixture containing the azabicyclohexene ester may be used directly in the subsequent hydrolysis step. In the subsequent hydrolysis step, the resulting ester of the acid whose carbon skeleton includes the unit II is converted into the free acid II or salt thereof by hydrolysis. The hydrolysis may be carried out by any of the methods normally used for the hydrolysis of esters, for example using acidic or basic catalysts, and whether an acid or a salt is formed depends of course on the conditions. In a preferred embodiment of the process according to the invention, an ester and not a salt of an ester is used as starting material, and the hydrolysis is carried out using water only, to avoid the introduction of inorganic ions into the reaction mixture. Such a procedure may facilitate workup of the final product. In an alternative embodiment of the process of the invention, the ester of the acid whose carbon skeleton includes the unit III is prepared, and then dehydrohalogenated under conditions which also cause hydrolysis of the ester group. The use of a relatively nucleophilic base, for example sodium hydroxide, facilitates such a process. If the free acid whose carbon skeleton includes the unit I, or a salt thereof, is used as starting material, it may be directly oxidised to the acid whose carbon skeleton includes the unit II or a salt thereof, or it may be converted indirectly by the process of N-chlorination or N-bromination followed by dehydrohalogenation as described above for the conversion of esters. Conditions for the direct oxidation or for the N-halogenation and subsequent dehydrohalogenation of an acid or salt are as described above for esters, except that it may be preferable to work in a reaction medium which consists of or includes water. The hydrogenation step of the process according to the invention may for example be carried out by using a hydride transfer agent; preferably however it is carried out using gaseous hydrogen in the presence of a homogeneous or, preferably, heterogeneous catalyst, for example a palladium or platinum catalyst, such as palladium charcoal or, preferably, platinum charcoal. The process may be carried out at atmospheric pressure but it is preferably carried out at elevated pressure, for example up to 150 atmospheres gauge. The hydrogenation reaction is preferably carried out at room temperature. It may however if desired be carried out at elevated temperature, for example up to 1000C. Any suitable solvent may be used. Water is especially preferred. Depending upon conditions, the monohydrate of an acid whose carbon skeleton includes the unit II may exist wholly or partly in tautomeric form. In aqueous solution, it is believed that an equilibrium exists between the bicyclic structure and the open chain structure: EMI6.1 This equilibrium may also exist under certain conditions in other solvents and even in the solid state. Elemental analysis alone cannot of course distinguish between the monohydrate of the bicyclic acid, and the open chain compound, but spectroscopic methods such as NMR can be used to detect either form. Throughout this specification and claims, it should be understood that any reference to the bicyclic acid or salt thereof includes the possiblity that the acid or salt may in fact be present wholly or partly as the open-chain tautomer Esters of the acid whose carbon skeleton includes the unit II are believed to exist very largely or entirely in bicyclic form. The acid 2-carboxy-3-azabicyclo03.1. hex-2-ene or a salt and/or amide, alkylamide, hydrazide or aikyThydrazide thereof may be used to sterilise the male anthers of plants, especially small-grain cereal plants, without substantially affecting female fertility. This makes it possible to produce F1 hybrids of selfpollinating plants using a simple chemical treatment. The invention therefore provides a pollen suppressing composition which comprises said acid or derivative thereof together with a suitable carrier. The invention further provides a method of sterilising the male anthers of plant, which comprises applying to the plant said acid or derivative thereof or a pollen-suppressing composition containing such a compound. The invention also provides a method of producing an F1 hybrid seed which comprises cross-pollinating a plant which has been treated by the sterilising process according to the invention with a second plant of a different strain. Preferably the active compound or composition is applied to a small-grain cereal plant, for example wheat or barley, when the plant is at a stage of growth between late tillering and emergence of the ear. The compound or composition is suitably applied at a dosage of active compound of from 0.05 to 2 kg/ha, preferably 0.25 to 1 kg/ha. Suitable salts of 2-carboxy-3-azabicyclo[3.1.0ghex-2-ene include hydrohalide and alkali metal salts. In an alkyl amide or alkylhydrazide, the or each alkyl group preferably has up to 4 carbon atoms. In a preferred embodiment of the invention, there is provided the monohydrate of 2-carboxy-3-azabi cyclo 3.1 .Olhex- 2-ene. The invention also provides a process for the preparation of 2-carboxy-3-azabicyclo[3.1.0]hex-2-ene or a salt and/or an amide, alkylamide, hydrazide or alkylhydrazide thereof, which comprises oxidising 2-carboxy-3-azabicyclo C3, 1.C hexane or a salt and/or an ester thereof, and if the starting material is an ester, hydrolysing the resulting ester of 2-carboxy-3-azabicyc1oC3.1.hex- 2-ene, and in the event of an amide, alkylamide, hydrazide or alkylhydrazide being required, converting the resulting acid or salt into the desired compound. The invention also provides a process for the preparation of the cis isomer of 2-carboxy-3-azabicyclo 1.hexane or a salt thereof, which comprises hydrogenating 2-carboxy-3-azabicyclo [3.1.0] hex-2-ene or a salt thereof. A carrier in a composition according to the invention is any material with which the active ingredient is formulated to facilitate application to the locus to be treated, or to facilitate storage, transport or handling. A carrier may be a solid or a liquid, including a material which is normally gaseous but which has been compressed to form a liquid, and any of the carriers normally used in formulating agricultural compositions may be used. Suitable solid carriers include natural and synthetic clays and silicates, for example natural silicas such as diatomaceous earths; magnesium silicates, for example talcs; magnesium aluminium silicates, for example a.ttapulgites and vermiculites; aluminium silicates, for example kaolinites, montmorillonites and micas; calcium carbonate: calcium sulphate; synthetic hydrated silicon oxides and synthetic calcium or aluminium silicates; elements, for example carbon and sulphur; natural and synthetic resins, for example coumarone resins, polyvinyl chloride, and styrene polymers and copolymers; solid polychlorophenols; bitumen; waxes, for example beeswax, paraffin wax, and chlorinated mineral waxes; and solid fertilisers, for example superphosphates. Suitable liquid carriers include water; alcohols, for example isopropanol and glycols; ketones, for example acetone, methyl ethyl ketone, methyl isobutyl ketone and cyclohexanone; ethers; aromatic or araliphatic hydrocarbons, for example benzene, toluene and xylene; petroleum fractions, for example kerosine and light mineral oils; chlorinated hydrocarbons, for example carbon tetrachloride, perchloroethylene and trichloroethane. Mixtures of different liquids are often suitable. Agricultural compositions are often formulated and transported in a concentrated form which is subsequently diluted by the user before application. The presence of small amounts of a carrier which is a surface-active agent facilitates this process of dilution. Thus preferably at least one carrier in a composition according to the invention is a surface-active agent. For example the composition may contain at least two carriers, at least one of which is a surface active agent. A surface-active agent may be an -emulsifying agent, a dispersing agent or a wetting agent; it may be nonionic or ionic. Examples of suitable surface-active agents include the sodium or calcium salts of polyacrylic acids and lignin sulphonic acids; the condensation products of fatty acids or aliphatic amines or amides containing at least 12 carbon atoms in tEe molecule with ethylene oxide and/or propylene oxide; fatty acid esters of glycerol, sorbitan, sucrose or pentaerythritol; condensates of these with ethylene oxide and/or propylene oxide; condensation products of fatty alcohol or alkyl phenols, for example - octylphenol or p-octylcresol, with ethylene oxide and/or propylene oxide; sulphates or sulphonates of these condensation products; alkali or alkaline earth metal salts, preferably sodium salts, of sulphuric or sulthonic acid esters containing at least 10 carbon atoms in the molecule, for example sodium lauryl sulphate, sodium secondary alkyl sulphates, sodium salts of sulphonated castor oil, and sodium alkylaryl sulphonatec such as sodium dodecylbenzene sulphonate; and polymers of ethylene oxide and copolymers of ethylene oxide and propylene oxide. The compositions of the invention may for example be formulated as wettable powders, dusts, granules, solutions, emulsifiable concentrates, emulsions, suspension concentrates and aerosols. Wettable powders usuallv contain 25, 50 and 752 w of active ingredient and usually contain, in addition to solid inert carrier, 3-10% w of a dispersing agent and, where necessary, 010% w of stabiliser(s) and/or other additives such as penetrants or stickers. Dusts are usually formulated as a dust concentrate having a similar compositions to that of a wettable powder but without a dispersant, and are diluted in the field with further solid carrier to give a composition usuallv containing 2-10% w of active ingredient. Granules are usually prepared to have a size between 10 and 100 BS mesh (1.676 - 0.152 mm), and may be manufactured by agglomeration or impregnation techniques. Generally, granules will contain 2-25% w active ingredient and 0-10% w of additives such as stabilisers, slow release modifiers and binding agents. Emulsifiable concentrates usually contain, in addition to a solvent and, when necessary, co-solvent, 10-50% w/v active ingredient, 2-20% w/v emulsifiers and 0-20% w/v of other additives such as stabilisers, penetrants and corrosion inhibitors. Suspension concentrates are usually compounded so as to obtain a stable, non-sedimenting flowable product and usuallv contain 1075 w active ingredient, 0.5-15/ w of dispersing agents, 0.1-10% w of suspending agents such as protective colloids and thixotropic agents, 0-10% w of other additives such as defoamers, corrosion inhibitors, stabilisers. penetrants and stickers, and water or an organic liquid in which the active ingredient is substantially insoluble; certain organic solids or inorganic salts may be present dissolved in the formulation to assist in preventing sedimentation or as anti-freeze agents for water. Aqueous disDersions and emulsions, for example compositions obtained by diluting a wettable powder or a concentrate according to the invention with water, also lie within the scope of the present invention. The said emulsions may be of the water-in-oil or of the oil-in-water type, and may have a thick 'mayonnaise'- like consistency. The compositions of the invention may also contain other ingredients, for example, other compounds possessing insecticidal, herbicidal or fungicidal properties. The following Examples illustrates the invention. Example 1 Conversion of trans 2-ethoxycarbonyl-3-azabicyclo (3.1.0') hexane into cis 2-carboxy-3-azabicyclor3.1.01hexane (a) Oxidation of starting ester (Method (i)) A mixture of the cis and trans isomers (ratio 55:45) of 2 ethoxycarbonyl-3-azabicyclo[3.1.0ihexane (62 g, 0.4 m) was added over 2 hours to N-chlorosuccinimide (56.0 g, 0.42 mol) in dimethyl ether (30 ml) undpr a nitrogen atmosphere, the mixture being cooled with ice to maintain the internal temperature at 18-21 C. The mixture was then filtered, and triethylamine (60.6 g, 0.6 mol) was added to the filtrate over 30 minutes. The mixture was then heated to reflux for 6 hours, and allowed to stand overnight at room temperature. It was then filtered, and on evaporation 66.3 g of crude 2 ethoxycarbonyl-3-azabicyclo [3.1. o3 hex-2-ene was obtained. The crude product was distilled to give 42.5 g of the pure product which had E boiling point of 56-580C at a pressure of 0.3-0.4 mm Hg. (b) Oxidation of starting ester (Method (ii)) The mixture of cis and trans isomers described in (a) above (50 g) was dissolved in n-hexane (250 ml) and manganese dioxide (200 g) was added in four portions over 2 hours, the mixture being stirred under a nitrogen atmosphere. The internal temperature rose to 35 0C. Stirring was continued overnight. A further portion of manganese dioxide was then added. and stirring was continued for a further 2 days. The mixture was then filtered and the solvent was stripped on a rotary evaporator to give a rather viscous crude product. This was distilled to give 32.7 g of the desired product. (c) Hydrolysis of intermediate ester 19.5 g (0.127 M) of 2-ethoxycarbonyl-3-azabicyclo±3.1.0jhex- 2-ene prepared as described in either (a) or (b) above, was added to demineralised water (175 ml) and the mixture was heated at reflux under a nitrogen atompsphere for two hours. Ethanol distilled off over this period. The mixture was then allowed to stand at room temperature overnight. Water was removed on a rotary evaporator until about 75 ml of mixture remained. Isopropyl alcohol (100 ml) was added, and the precipitate which formed on cooling was filtered off and washed first with isopropyl alcohol and then with hexane. After drying in an oven overnight at 600C, 13.2 g of a white solid, melting point 124-1260C (with decomposition) were obtained. Elemental Analysis C H N Calculated for C6H903N 50.3 6.3 9.8 Found 5o.4 6.3 9.8 The elemental analysis conforms to C6HgO3N, the empirical formula of the tautomers: EMI11.1 The electron impact mass spectrum of the solid, indicated that the solid was largely or entirely the bicyclic structure. The NMR spectrum in deuterated dimethylsuphoxide indicated only the bicyclic structure. The NMR spectrum in D20 solu+ion, however, indicated the presence of both the bicyclic and the open-chain structure. (d) Hydrogenation of product from (c) 0.2 g of Adam's Catalyst (platinum oxide) were added to de mineralised water (100 ml) in a Parr Shaker. The mixture was flushed with nitrogen and then with hydrogen at 1 atmos phere gauge pressure. The product from step (c) above (6 g) was added and the hydrogen pressure was increased to 4 atmospheres gauge. The mixture was shaken for 3.75 hours. The catalyst was filtered off, and the water was removed until a sticky residue remained. This residue was treated with isopropyl alcohol (75 ml), and the resulting crystalline precipitate was filtered off and dried overnight in an oven at 65-700C. 4.6 g of 2-carboxy-3-azabicyclo[3.1.0]hexane, melting at 245-2460C (with decomposition) were obtained. NMR showed that the product was the cis isomer with isomeric purity of greater than 95%. Example 2 Demonstration of pollen-surpressing activity Spring wheat, variety sicco, was propagated in a glass-house in 13 cm pots containing a loam-based compost. Supplementary lighting was provided by high-pressure mercury vapor lamps to give a constant day length of 16 hours. The temperature was maintained at approximately 200C. 2-carboxy-3-azabicylo[3.1.00hex-2-ene prepared by steps (a) and (c) of Example 1 was formulated as an aqueous solution containing 0.1% nonidet P40 (trade mark) as wetting agent and 1% acetone to aid solubility. This formulation was diluted with water to various concentrations and sprayed onto plants to runoff. The plants were treated at the growth stage when the second node of the plant was just detectable. At ear emergence but before anthesis, 5 heads from each treated pot were placed in cellophane bags to prevent crosspollination. At maturity, the bagged ears were harvested, and the seed set on both the main stems and tillers was recorded and compared with untreated controls. The results are shown in the following Table. TABLE Reduction in seed set (% relative to control) Dosage ppm Main Stems Tillers 200 7 0 1000 79 86

Claims: CLAIMS 1. A process for the conversion of the trans isomer of an acid whose carbon skeleton includes the unit EMI14.1 or a salt, ester, or salt of an ester thereof, into the cis isomer of such a compound which comprises converting the trans isomer into an acid whose carbon skeleton includes the unit EMI14.2 or a salt thereof, and subsequently hydrogenating said compound; and, in the event of an ester or salt thereof being required, converting the resulting free acid or salt thereof into the required ester or salt thereof. 2. A process as claimed in Claim 1, characterised in that the starting material is an ester of an acid whose carbon skeleton includes the unit I. 3. A process as claimed in Claim 2, characterised in that the ester is an alkyl ester having 1 to 4 carbon atoms in the alkyl group. 4. A process as claimed in either Claim 2 or Claim 3, character ised in that the starting ester is converted into an ester of the acid whose carbon skeleton includes the unit II either directly using an oxidising agent or by chlorination or bromination of the starting ester to produce an ester of an acid whose carbon skeleton includes the unit EMI15.1 in which Hal is a chlorine or bromine atom, and subsequently dehydrohalogenating the N-halo compound; and subsequently the resulting ester is hydrolysed to produce an acid whose carbon skeleton includes the unit II or a salt thereof. 5. A process as claimed in Claim 4, characterised in that the starting ester is chlorinated using N-chloro succinimide, t butyl hypochlorite or sodium hypochlorite. 6. A process as claimed in Claim 1, characterised in that a free acid whose carbon skeleton includes the unit I or a salt thereof, is N-chlorinated using sodium hypochlorite, and subsequently dehydrohalogenated to produce an acid whose carbon skeleton includes the unit II or a salt thereof. 7. A process as claimed in any one of Claims 4 to 6, character ised in that the halogenation is carried out at a temperature in the range of from -100C to +300C. 8. A process as claimed in any one of Claims 4 to 7, character ised in that the dehydrohalogenation step is carried out using an alkali metal hydroxide or alkoxide, or a tertiary amine. 9. A process as claimed in any one of Claims 4 to 8, character ised in that the dehydrohalogenation step is carried out at a temperature of up to 1500C. 10. A process as claimed in Claim 4, characterised in that the starting ester is directly oxidised using manganese dioxide. 11. A process as claimed in any one of Claims 1 to 10, character ised in that the hydrogenation step is carried out using gaseous hydrogen in the presence of a heterogeneous catalyst. 12. A process as claimed in Claim 11, characterised in that the catalyst comprises palladium or platinum. 13. A pollen suppressing composition which comprises 2-carboxy 3-azabicyclo.l.0hex-2-ene or a salt and/or amide, alkyl amide, hydrazide or alkylhydrazide thereof, together with a carrier. 14. A composition as claimed in Claim 13, which comprises at least two carriers, at least one of which is a surface active agent. 15. A method of sterilising the male anthers of a plant, charac terised in that it comprises applying to the plant 2-carboxy 3-azabicycloc3.1.03hex-2-ene or a salt and/or amide, alkyla mide, hydrazide or alkylhydrazide thereof, or a composition as claimed in either Claim 13 or Claim 14. 16. A method of producing F1 hybrid seed, characterised in that it comprises cross-pollinating a plant which has been treated by a process as claimed in Claim 15, with a second plant of a different strain. 17. A process for the preparation of 2-carboxy- 3-azabicyclo r 1 hex-2-ene or a salt and/or an amide, alkylamide, hydrazide or alkylhydrazide thereof, which comprises oxidising 2 carboxy3-azabicyclo{3.l.0}hexane or a salt and/or an ester thereof, and if the starting material is an ester, hydrolysing the resulting ester of 2-carboxy-3-azabicyclo03.1. hex-2- ene, and in the event of an amide, alkylamide, hydrazide or alkylhydrazide being required, converting the resulting acid or salt into the desired compound. 18. A process for the preparation of the cis isomer of 2-carboxy 3-azabicyclo1.hexane or a salt thereof, which comprises hydrogenating 2-carboxy-3-azabicyclo [3.1.0] hex-2-ene or a salt thereof. 19. 2-Carboxy-3-azabicyclo [3.1.0] hex-2-ene or a salt and/or amide, alkylamide, hydrazide or alkylhydrazide thereof. 20. The monohydrate of 2-carboxy-3-azabicyclo [3.1.0] hex-2-ene.

Inventors: MASON, RONALD FRANK, WOOD, DEREK ALEXANDER
Applicants: SHELL INTERNATIONALE RESEARCH MAATSCHAPPIJ B.V.
Application year: 1980
Main classification: C07D209
IPC codes: A01H1, A01N43, B01J23, C07B61, C07D209